Ye, Xiaolu <br/><br/>
Dihydromyricetin attenuates hypertrophic scar formation by targeting activin receptor-like kinase 5.  [electronic resource] 

 -  European journal of pharmacology  Jun 2019 
 - 58-67 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2019.02.039  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Animals<br/>Biocatalysis<br/>Cell Proliferation--drug effects<br/>Cicatrix, Hypertrophic--drug therapy<br/>Female<br/>Fibroblasts--drug effects<br/>Flavonols--metabolism<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Molecular Docking Simulation<br/>Molecular Targeted Therapy<br/>Phosphorylation--drug effects<br/>Protein Conformation<br/>Receptor, Transforming Growth Factor-beta Type I--chemistry<br/>Smad2 Protein--metabolism<br/>Smad3 Protein--drug effects<br/>Young Adult